DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

SAYER KEVIN R

Brown Michael Jon

FOLETTA MARK G

Coleman Jon

Heller Bridgette P

Hybrid Position/Swing Trader, Cancer Survivor, Father, Brother, Uncle, Wine lover and Windsurfer. All opinions are my own and not investment advice.

Jonathan Whitcraft

I have seen the stock market change people's lives! It can change yours too. Never Give Up! You may find my best stock ideas at: https://t.co/rqfRosoA4A

Marty Chargin

Real-time signal from 500+ top analysts on X, powered by AI. Price targets & investment scores on every ticker. and AI recommendation. On Web, iPhone & Android.

DexCom Inc (DXCM) Stock Price, Analysis & Trade Signals